CA1181072A - Preparation d'hydroxy-4-quinoleines - Google Patents
Preparation d'hydroxy-4-quinoleinesInfo
- Publication number
- CA1181072A CA1181072A CA000394261A CA394261A CA1181072A CA 1181072 A CA1181072 A CA 1181072A CA 000394261 A CA000394261 A CA 000394261A CA 394261 A CA394261 A CA 394261A CA 1181072 A CA1181072 A CA 1181072A
- Authority
- CA
- Canada
- Prior art keywords
- chloro
- tetrahydro
- quinoline
- quinolinone
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000004331 4-hydroxyquinolines Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000003054 catalyst Substances 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims abstract description 12
- 125000005843 halogen group Chemical group 0.000 claims abstract description 12
- 239000002253 acid Substances 0.000 claims abstract description 11
- 229910052697 platinum Inorganic materials 0.000 claims abstract description 11
- 229910052707 ruthenium Inorganic materials 0.000 claims abstract description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000001301 oxygen Substances 0.000 claims abstract description 9
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 9
- 239000000956 alloy Substances 0.000 claims abstract description 7
- 229910045601 alloy Inorganic materials 0.000 claims abstract description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 6
- 238000006356 dehydrogenation reaction Methods 0.000 claims abstract description 6
- 239000003960 organic solvent Substances 0.000 claims abstract description 6
- PMZDQRJGMBOQBF-UHFFFAOYSA-N quinolin-4-ol Chemical compound C1=CC=C2C(O)=CC=NC2=C1 PMZDQRJGMBOQBF-UHFFFAOYSA-N 0.000 claims abstract description 6
- 230000003197 catalytic effect Effects 0.000 claims abstract description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 4
- 239000011707 mineral Substances 0.000 claims abstract description 4
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 3
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 3
- 125000001424 substituent group Chemical group 0.000 claims abstract description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims abstract description 3
- 238000002360 preparation method Methods 0.000 claims abstract 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims description 30
- 239000011541 reaction mixture Substances 0.000 claims description 9
- 238000009835 boiling Methods 0.000 claims description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 2
- RELMFMZEBKVZJC-UHFFFAOYSA-N 1,2,3-trichlorobenzene Chemical group ClC1=CC=CC(Cl)=C1Cl RELMFMZEBKVZJC-UHFFFAOYSA-N 0.000 claims 1
- WVEIRFXVLXAKLS-UHFFFAOYSA-N 7-chloro-1,2,3,4-tetrahydroquinoline Chemical compound C1CCNC2=CC(Cl)=CC=C21 WVEIRFXVLXAKLS-UHFFFAOYSA-N 0.000 claims 1
- 239000012736 aqueous medium Substances 0.000 claims 1
- 239000002609 medium Substances 0.000 claims 1
- 230000035943 smell Effects 0.000 claims 1
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical group [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 abstract description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 16
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 15
- 239000008346 aqueous phase Substances 0.000 description 10
- HXEWMTXDBOQQKO-UHFFFAOYSA-N 4,7-dichloroquinoline Chemical compound ClC1=CC=NC2=CC(Cl)=CC=C21 HXEWMTXDBOQQKO-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 230000009466 transformation Effects 0.000 description 9
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 8
- 238000004817 gas chromatography Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 6
- XMFXTXKSWIDMER-UHFFFAOYSA-N 7-chloro-1h-quinolin-4-one Chemical compound ClC1=CC=C2C(O)=CC=NC2=C1 XMFXTXKSWIDMER-UHFFFAOYSA-N 0.000 description 5
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 5
- 238000007792 addition Methods 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- -1 4-diethylamino-1-methyl butylamino Chemical group 0.000 description 4
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 4
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 229910052796 boron Inorganic materials 0.000 description 4
- 125000001309 chloro group Chemical group Cl* 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- PBKONEOXTCPAFI-UHFFFAOYSA-N 1,2,4-trichlorobenzene Chemical compound ClC1=CC=C(Cl)C(Cl)=C1 PBKONEOXTCPAFI-UHFFFAOYSA-N 0.000 description 3
- XNMYNYSCEJBRPZ-UHFFFAOYSA-N 2-[(3-butyl-1-isoquinolinyl)oxy]-N,N-dimethylethanamine Chemical compound C1=CC=C2C(OCCN(C)C)=NC(CCCC)=CC2=C1 XNMYNYSCEJBRPZ-UHFFFAOYSA-N 0.000 description 3
- KNDOFJFSHZCKGT-UHFFFAOYSA-N 4-chloroquinoline Chemical compound C1=CC=C2C(Cl)=CC=NC2=C1 KNDOFJFSHZCKGT-UHFFFAOYSA-N 0.000 description 3
- JPVTWKDGBWUNBQ-UHFFFAOYSA-N 7-methyl-1h-quinolin-4-one Chemical compound OC1=CC=NC2=CC(C)=CC=C21 JPVTWKDGBWUNBQ-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000010908 decantation Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 3
- 229910052753 mercury Inorganic materials 0.000 description 3
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 229960005038 quinisocaine Drugs 0.000 description 3
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 3
- 229930185107 quinolinone Natural products 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- TWYVITBRDNFBNT-UHFFFAOYSA-N 7-chloro-2-methyl-1h-quinolin-4-one Chemical compound C1=C(Cl)C=C2NC(C)=CC(=O)C2=C1 TWYVITBRDNFBNT-UHFFFAOYSA-N 0.000 description 2
- KDYVCOSVYOSHOL-UHFFFAOYSA-N 7-methylquinoline Chemical compound C1=CC=NC2=CC(C)=CC=C21 KDYVCOSVYOSHOL-UHFFFAOYSA-N 0.000 description 2
- UDRWADJLLWWJOE-UHFFFAOYSA-N 8-(trifluoromethyl)-1H-quinolin-4-one Chemical compound C1=CC=C2C(O)=CC=NC2=C1C(F)(F)F UDRWADJLLWWJOE-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000257303 Hymenoptera Species 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 2
- 229960001650 glafenine Drugs 0.000 description 2
- GWOFUCIGLDBNKM-UHFFFAOYSA-N glafenine Chemical compound OCC(O)COC(=O)C1=CC=CC=C1NC1=CC=NC2=CC(Cl)=CC=C12 GWOFUCIGLDBNKM-UHFFFAOYSA-N 0.000 description 2
- NDJKXXJCMXVBJW-UHFFFAOYSA-N heptadecane Chemical compound CCCCCCCCCCCCCCCCC NDJKXXJCMXVBJW-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- KUDPGZONDFORKU-UHFFFAOYSA-N n-chloroaniline Chemical compound ClNC1=CC=CC=C1 KUDPGZONDFORKU-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 239000003507 refrigerant Substances 0.000 description 2
- ZDBWSIGYOMJBOA-UHFFFAOYSA-N 1-chloro-3,4-dihydroquinolin-2-one Chemical compound C1=CC=C2N(Cl)C(=O)CCC2=C1 ZDBWSIGYOMJBOA-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- VMGPYGSLEMLNBZ-UHFFFAOYSA-N 2-chloro-6H-quinolin-7-one Chemical compound ClC1=NC2=CC(CC=C2C=C1)=O VMGPYGSLEMLNBZ-UHFFFAOYSA-N 0.000 description 1
- 150000004325 8-hydroxyquinolines Chemical class 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- OVCDSSHSILBFBN-UHFFFAOYSA-N Amodiaquine Chemical compound C1=C(O)C(CN(CC)CC)=CC(NC=2C3=CC=C(Cl)C=C3N=CC=2)=C1 OVCDSSHSILBFBN-UHFFFAOYSA-N 0.000 description 1
- XVRWQISNHFVVNP-UHFFFAOYSA-N CC(C(=O)O)(NC1=CC=CC=C1)Cl Chemical compound CC(C(=O)O)(NC1=CC=CC=C1)Cl XVRWQISNHFVVNP-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- APQPGQGAWABJLN-UHFFFAOYSA-N Floctafenine Chemical compound OCC(O)COC(=O)C1=CC=CC=C1NC1=CC=NC2=C(C(F)(F)F)C=CC=C12 APQPGQGAWABJLN-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 229960001444 amodiaquine Drugs 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 229940033495 antimalarials Drugs 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 238000009739 binding Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000005695 dehalogenation reaction Methods 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229960003240 floctafenine Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 206010037833 rales Diseases 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Catalysts (AREA)
- Quinoline Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8100764A FR2498186A1 (fr) | 1981-01-16 | 1981-01-16 | Preparation de la chloro-5, -6, -7 ou -8 hydroxy-4 quinoleine |
| FR8100764 | 1981-01-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1181072A true CA1181072A (fr) | 1985-01-15 |
Family
ID=9254222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000394261A Expired CA1181072A (fr) | 1981-01-16 | 1982-01-15 | Preparation d'hydroxy-4-quinoleines |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4412076A (https=) |
| EP (1) | EP0056765B1 (https=) |
| JP (1) | JPS57171970A (https=) |
| KR (1) | KR870001897B1 (https=) |
| AT (1) | ATE13881T1 (https=) |
| CA (1) | CA1181072A (https=) |
| DE (1) | DE3264152D1 (https=) |
| DK (1) | DK149450C (https=) |
| FR (1) | FR2498186A1 (https=) |
| HU (1) | HU184984B (https=) |
| IE (1) | IE51958B1 (https=) |
| IN (1) | IN158326B (https=) |
| ZA (1) | ZA82278B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2528836A1 (fr) * | 1982-06-17 | 1983-12-23 | Rhone Poulenc Sante | Procede de preparation d'hydroxy-4 quinoleines |
| RU2073673C1 (ru) * | 1987-10-19 | 1997-02-20 | Пфайзер Инк. | Рацемические и оптические активные производные тетралина и 7-гидрокситетралина |
| US6166031A (en) * | 1987-10-19 | 2000-12-26 | Pfizer Inc, | Substituted tetralins, chromans and related compounds in the treatment of asthma |
| WO1995023787A1 (en) * | 1994-03-01 | 1995-09-08 | Ishihara Sangyo Kaisha, Ltd. | Process for producing 5,7-dichloro-4-hydroxyquinoline |
| CN116588893B (zh) * | 2023-06-08 | 2025-11-11 | 中国科学院宁波材料技术与工程研究所 | 储氢材料、储氢组合物及应用、氢气存储及脱附方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2558211A (en) * | 1949-04-14 | 1951-06-26 | Lilly Co Eli | Preparation of 4-hydroxyquinoline compounds |
-
1981
- 1981-01-16 FR FR8100764A patent/FR2498186A1/fr active Granted
-
1982
- 1982-01-14 JP JP57003536A patent/JPS57171970A/ja active Granted
- 1982-01-15 CA CA000394261A patent/CA1181072A/fr not_active Expired
- 1982-01-15 AT AT82400079T patent/ATE13881T1/de active
- 1982-01-15 DK DK17382A patent/DK149450C/da not_active IP Right Cessation
- 1982-01-15 HU HU82120A patent/HU184984B/hu not_active IP Right Cessation
- 1982-01-15 IE IE76/82A patent/IE51958B1/en unknown
- 1982-01-15 DE DE8282400079T patent/DE3264152D1/de not_active Expired
- 1982-01-15 KR KR8200162A patent/KR870001897B1/ko not_active Expired
- 1982-01-15 EP EP82400079A patent/EP0056765B1/fr not_active Expired
- 1982-01-15 US US06/339,723 patent/US4412076A/en not_active Expired - Fee Related
- 1982-01-15 IN IN35/DEL/82A patent/IN158326B/en unknown
- 1982-01-15 ZA ZA82278A patent/ZA82278B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0249305B2 (https=) | 1990-10-29 |
| HU184984B (en) | 1984-11-28 |
| KR870001897B1 (ko) | 1987-10-21 |
| ZA82278B (en) | 1982-11-24 |
| DK149450B (da) | 1986-06-16 |
| EP0056765A1 (fr) | 1982-07-28 |
| FR2498186A1 (fr) | 1982-07-23 |
| FR2498186B1 (https=) | 1983-10-28 |
| IN158326B (https=) | 1986-10-18 |
| DE3264152D1 (en) | 1985-07-25 |
| IE51958B1 (en) | 1987-04-29 |
| EP0056765B1 (fr) | 1985-06-19 |
| DK17382A (da) | 1982-07-17 |
| JPS57171970A (en) | 1982-10-22 |
| IE820076L (en) | 1982-07-16 |
| ATE13881T1 (de) | 1985-07-15 |
| US4412076A (en) | 1983-10-25 |
| DK149450C (da) | 1986-11-24 |
| KR830009033A (ko) | 1983-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1171861A (fr) | Procede de preparation d'amino-4 chloro-7 quinoleines | |
| EP0049555B1 (fr) | Nouveaux dérivés de l'acide 2-trifluorométhyl-4-hydroxy-3-quinoline carboxylique et leur procédé de préparation | |
| CA1181072A (fr) | Preparation d'hydroxy-4-quinoleines | |
| EP0719764A1 (fr) | Dérivés de 3-phénylisoquinoléin-l (2H)-one comme ligands des récepteurs GABA | |
| EP0139584B1 (fr) | Dérivés d'imidazoline, leur préparation et leur application en thérapeutique | |
| CA1181073A (fr) | Procede de preparation de quinolinones-4 | |
| CA1193262A (fr) | Procede de preparation d'hydroxy-4 quinoleines | |
| EP0177398B1 (fr) | Dérivés chlores de l'hexadécène, leur préparation et leur emploi dans la synthèse de la vitamine e | |
| EP0143018B1 (fr) | Procédé de préparation de quinolinones-4 | |
| EP0176435B1 (fr) | Dérivés du tocophérol, leur préparation et leur emploi | |
| JPH0549657B2 (https=) | ||
| CA2224598A1 (en) | A process for preparing 1-(3-trialkylsilylphenyl)-2,2,2-trifluoromethyl ethanone derivatives | |
| FR2570372A1 (fr) | Tetrachloro-1,7,11,15 tetramethyl-3,7,11,15 hexadecene-2, sa preparation et son emploi | |
| EP0140748B1 (fr) | Procédé de préparation de quinolinones-4 | |
| EP0478417A1 (fr) | Procédé de synthèse de monohalogénoalkylferrocènes | |
| FR2750427A1 (fr) | Derives de 1-oxo-1, 2-dihydroisoquinoleine-4-propanamide, leur preparation et leur application en therapeutique | |
| EP0056764B1 (fr) | Procédé de préparation de la chloro-7 tétrahydro-1,2,3,4 quinolinone-4 | |
| KR840000278B1 (ko) | α，α，α－트리플루오로－ｏ－톨루익플루오라이드의 제조방법 | |
| Hager et al. | Synthetic Analogs of the Adrenal Cortical Hormones. II. Synthesis of 4, 4′-bis (acetoxyacetyl)-α, α′-diethylstilbene | |
| FR2536400A1 (fr) | 3-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxopurine-7-acetyl)-8-(2-phenylethyl)-1-oxa-3,8-diazaspiro (4,5) decane-2-one, utile comme bronchodilatateur ou anti-inflammatoire, et son procede de preparation | |
| EP0179685A1 (fr) | Procédé de préparation d'esters allyliques tertiaires éventuellement halogénés | |
| FR2578843A1 (fr) | Tetramethyl-2,5,7,8 (trichloro-4',8',12' trimethyl-4',8',12' tridecyl)-2 chromanol-6 et son acetate, leur preparation et leur emploi | |
| MC712A1 (fr) | Nouveaux composés à fonction amide et préparation de ceux-ci | |
| FR2556345A1 (fr) | Derive de pyrrolo(3,2,1-hi) indole, sa preparatio n et son application en therapeutique | |
| FR2553416A1 (fr) | Derive de pyrrolo-quinoline, sa preparation et son application en therapeutique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |